Pantoprazol Vir (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Vir, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat gastro‑reflux related conditions in adults and children. GNH USA supplies Pantoprazol Vir as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Pantoprazol Vir as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Vir is a proton pump inhibitor that acts on the acid‑secretion pathway in the stomach.

- Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the condition.

Pantoprazol Vir may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild, transient headache. - Diarrhea: loose stools that usually resolve without treatment. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area. - Flatulence: increased gas production. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, dizziness, or trouble breathing. - Clostridioides difficile infection: persistent watery diarrhea, abdominal cramping.\n- Low magnesium levels: muscle cramps, irregular heartbeat, seizures. - Bone fractures: increased risk of hip, wrist, or spine fractures with long‑term use. - Acute interstitial nephritis: kidney inflammation presenting with fever, rash, and urinary changes.

When prescribing Pantoprazol Vir, clinicians should consider several safety aspects.

- Assess renal function: adjust use in severe renal impairment. - Monitor magnesium: long‑term therapy may lower serum magnesium. - Evaluate bone health: prolonged use may affect calcium absorption. - Review concomitant medications: potential for altered absorption of drugs requiring acidic pH. - Pregnancy and lactation: use only if clearly needed. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazol Vir can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Ketoconazole: reduced absorption due to increased gastric pH. - Atazanavir: markedly decreased plasma concentrations. - Warfarin: potential increase in INR, requiring closer monitoring.

Moderate Interactions (Monitor Closely): - Digoxin: may increase serum levels. - Methotrexate: reduced clearance, especially at high doses. - Iron supplements: decreased absorption; separate dosing by at least 2 hours. - Mycophenolate mofetil: lowered exposure, may require dose adjustment.